---
title: Papaverine
description: 
published: true
date: 2025-08-08T02:11:15.240Z
tags: chemicals
editor: markdown
dateCreated: 2025-08-08T02:11:13.435Z
---

| **Other Names** | **Literature** |
|---|---|
| 1-(3,4-dimethoxybenzyl)-6,7-dimethoxyisochinoline,<br><br>papaverin, papaverina, papaverine<br><br>Substance type: opium alkaloid<br><br>Papaverine is a component of opium (0.3 to 0.80/0)<br>and was named after the genus Papaver (cf. Papaver<br>somniferum). Papaverine has very weak psychoactive<br>properties but is a powerful vasodilator.<br><br>Effective dosages start at 200 mg. An extract of<br>Nuphar lutea has similar effects.<br><br>In recent years, papaverine has been used to<br>treat impotence, often with good success (Mellinger<br>et al. 1987). When used for this purpose, the substance<br>is injected directly into the corpus cavernosum<br>when the penis is flaccid (so-called SKAT<br>therapy; cf. Ernst et al. 1993). Among the problems<br>that this method may cause are painful priapism<br>(persistent erections for up to thirty-six hours<br>without sexual arousal!) and inflammation of the<br>penis (Sanders 1985).<br><br>**Commercial Forms and Regulations**<br><br>The substance, available as papaverine hydrochloride,<br>is sold in suppository form and in<br>solution for injection. Papaverine is available only<br>with a prescription. | See also the entries for Papaver somniferum and<br>opium alkaloids.<br><br>Ernst, Gunter, Hans Finck, and Dieter Weinert. 1993.<br>Dem Manne kann geholfen werden. Munich:<br>Ehrenwirth.<br><br>Mellinger, Brett C., E. Darracott Vaughan, Stephen L.<br>Thompson, and Marc Goldstein. 1987.<br>Correlation between intracavernous papaverine<br>injection and Doppler analysis in impotent men.<br>Urology 30 (5): 416-19.<br><br>Porst, H. 1996. Orale und intracavernose<br>Pharmakotherapie. TW Urologie Nephrologie 8<br>(2): 88-94.<br><br>Sanders, Kevin. 1985. 30-Stunden Erektion.<br>Penthouse 4/85:65-68, 196, 200.<br><br>Schnyder von Wartensee, M., A. Sieber, and U. E.<br>Studer. 1988. Therapie der erektilen Dysfunktion<br>mit Papaverin-21h Jahre Erfahrung. Schweizer<br>medizinische Wochenschrift 118 (30): 1099-1103. |